Search

Robert Clinton Hayes

Examiner (ID: 11727, Phone: (571)272-0885 , Office: P/1649 )

Most Active Art Unit
1649
Art Unit(s)
1647, 1645, 1812, 1644, 1621, 1649, 1818
Total Applications
994
Issued Applications
476
Pending Applications
94
Abandoned Applications
425

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17625759 [patent_doc_number] => 20220160774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-26 [patent_title] => FUNCTIONAL PREDICTION OF CELLULAR FUNCTIONS BY MEANS OF MICRORNA EXPRESSSION PROFILING IN MESENCHYMAL STEM CELLS [patent_app_type] => utility [patent_app_number] => 17/669675 [patent_app_country] => US [patent_app_date] => 2022-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18825 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17669675 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/669675
FUNCTIONAL PREDICTION OF CELLULAR FUNCTIONS BY MEANS OF MICRORNA EXPRESSSION PROFILING IN MESENCHYMAL STEM CELLS Feb 10, 2022 Abandoned
Array ( [id] => 17673047 [patent_doc_number] => 20220186214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => PROMOTER FOR THE EXPRESSION OF GENES [patent_app_type] => utility [patent_app_number] => 17/570602 [patent_app_country] => US [patent_app_date] => 2022-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8972 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17570602 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/570602
PROMOTER FOR THE EXPRESSION OF GENES Jan 6, 2022 Abandoned
Array ( [id] => 18806088 [patent_doc_number] => 20230380417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-30 [patent_title] => A STORAGE METHOD OF HUMAN CORNEAL ENDOTHELIAL CELLS AND/OR HUMAN CORNEAL ENDOTHELIAL PRECURSOR CELLS [patent_app_type] => utility [patent_app_number] => 18/032726 [patent_app_country] => US [patent_app_date] => 2021-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18751 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 214 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18032726 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/032726
Storage method of human corneal endothelial cells and/or human corneal endothelial precursor cells Oct 18, 2021 Issued
Array ( [id] => 18150443 [patent_doc_number] => 20230024301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-26 [patent_title] => TREATMENT OF DISEASES CAUSED BY FRAME SHIFT MUTATIONS [patent_app_type] => utility [patent_app_number] => 17/765804 [patent_app_country] => US [patent_app_date] => 2020-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22062 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17765804 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/765804
TREATMENT OF DISEASES CAUSED BY FRAME SHIFT MUTATIONS Oct 1, 2020 Pending
Array ( [id] => 17852178 [patent_doc_number] => 20220282220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => METHOD FOR PREPARATION OF IMMORTALIZED STEM CELL LINE AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/629591 [patent_app_country] => US [patent_app_date] => 2020-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15081 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17629591 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/629591
METHOD FOR PREPARATION OF IMMORTALIZED STEM CELL LINE AND USE THEREOF Jul 23, 2020 Abandoned
Array ( [id] => 16326907 [patent_doc_number] => 20200297872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-24 [patent_title] => DELIVERY OF POLYNUCLEOTIDES USING RECOMBINANT AAV9 [patent_app_type] => utility [patent_app_number] => 16/890666 [patent_app_country] => US [patent_app_date] => 2020-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16725 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16890666 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/890666
DELIVERY OF POLYNUCLEOTIDES USING RECOMBINANT AAV9 Jun 1, 2020 Abandoned
Array ( [id] => 17719045 [patent_doc_number] => 20220211764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-07 [patent_title] => NEURAL CELL POPULATION, NEURAL CELL-CONTAINING PREPARATION, AND METHOD FOR PRODUCING SAID POPULATION AND PREPARATION [patent_app_type] => utility [patent_app_number] => 17/611007 [patent_app_country] => US [patent_app_date] => 2020-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11850 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17611007 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/611007
NEURAL CELL POPULATION, NEURAL CELL-CONTAINING PREPARATION, AND METHOD FOR PRODUCING SAID POPULATION AND PREPARATION May 13, 2020 Pending
Array ( [id] => 16326865 [patent_doc_number] => 20200297830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-24 [patent_title] => SEQUENCE ARRANGEMENTS AND SEQUENCES FOR NEOEPITOPE PRESENTATION [patent_app_type] => utility [patent_app_number] => 16/874104 [patent_app_country] => US [patent_app_date] => 2020-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15658 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16874104 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/874104
SEQUENCE ARRANGEMENTS AND SEQUENCES FOR NEOEPITOPE PRESENTATION May 13, 2020 Abandoned
Array ( [id] => 20593827 [patent_doc_number] => 12577531 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-17 [patent_title] => Microglia-sufficient brain organoids [patent_app_type] => utility [patent_app_number] => 17/599995 [patent_app_country] => US [patent_app_date] => 2020-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 30 [patent_no_of_words] => 3531 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 340 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17599995 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/599995
Microglia-sufficient brain organoids Mar 29, 2020 Issued
Array ( [id] => 17671009 [patent_doc_number] => 20220184176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => AMPHIPHYSIN / BIN1 FOR THE TREATMENT OF AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY [patent_app_type] => utility [patent_app_number] => 17/440807 [patent_app_country] => US [patent_app_date] => 2020-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15835 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17440807 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/440807
AMPHIPHYSIN / BIN1 FOR THE TREATMENT OF AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY Mar 19, 2020 Abandoned
Array ( [id] => 16267316 [patent_doc_number] => 20200268803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-27 [patent_title] => USE OF LIFR OR FGFR3 AS A CELL SURFACE MARKER FOR ISOLATING HUMAN CARDIAC VENTRICULAR PROGENITOR CELLS [patent_app_type] => utility [patent_app_number] => 16/795041 [patent_app_country] => US [patent_app_date] => 2020-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22702 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795041 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/795041
USE OF LIFR OR FGFR3 AS A CELL SURFACE MARKER FOR ISOLATING HUMAN CARDIAC VENTRICULAR PROGENITOR CELLS Feb 18, 2020 Abandoned
Array ( [id] => 20413053 [patent_doc_number] => 12496315 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-16 [patent_title] => Compositions for drug delivery and methods of use thereof [patent_app_type] => utility [patent_app_number] => 16/730603 [patent_app_country] => US [patent_app_date] => 2019-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 95 [patent_figures_cnt] => 191 [patent_no_of_words] => 29196 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 245 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16730603 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/730603
Compositions for drug delivery and methods of use thereof Dec 29, 2019 Issued
Array ( [id] => 17299841 [patent_doc_number] => 20210395680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => COMPOSITION AND KIT FOR DIFFERENTIATION OF STEM CELLS INTO NEURAL PROGENITOR CELLS, AND METHOD USING SAME [patent_app_type] => utility [patent_app_number] => 17/290085 [patent_app_country] => US [patent_app_date] => 2019-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4327 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17290085 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/290085
COMPOSITION AND KIT FOR DIFFERENTIATION OF STEM CELLS INTO NEURAL PROGENITOR CELLS, AND METHOD USING SAME Oct 22, 2019 Pending
Array ( [id] => 17561786 [patent_doc_number] => 20220125935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => COMPOSITION FOR PREVENTING OR TREATING ATOPIC DERMATITIS COMPRISING SKIN-PENETRATING NUCLEIC ACID COMPLEX AS EFFECTIVE COMPONENT [patent_app_type] => utility [patent_app_number] => 17/292404 [patent_app_country] => US [patent_app_date] => 2019-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14336 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17292404 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/292404
COMPOSITION FOR PREVENTING OR TREATING ATOPIC DERMATITIS COMPRISING SKIN-PENETRATING NUCLEIC ACID COMPLEX AS EFFECTIVE COMPONENT Oct 22, 2019 Abandoned
Array ( [id] => 17563418 [patent_doc_number] => 20220127567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => METHOD FOR PRODUCING ASTROCYTES [patent_app_type] => utility [patent_app_number] => 17/275395 [patent_app_country] => US [patent_app_date] => 2019-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8610 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17275395 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/275395
METHOD FOR PRODUCING ASTROCYTES Sep 8, 2019 Abandoned
Array ( [id] => 16793208 [patent_doc_number] => 20210123025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-29 [patent_title] => CELLULAR AGGREGATES FOR USE IN VASCULARISATION THERAPY [patent_app_type] => utility [patent_app_number] => 17/257457 [patent_app_country] => US [patent_app_date] => 2019-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16972 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17257457 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/257457
CELLULAR AGGREGATES FOR USE IN VASCULARISATION THERAPY Jul 1, 2019 Abandoned
Array ( [id] => 16484235 [patent_doc_number] => 20200377836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-03 [patent_title] => MEMBRANE AND METHOD FOR CULTURE AND DIFFERENTIATION OF CELLS [patent_app_type] => utility [patent_app_number] => 16/429042 [patent_app_country] => US [patent_app_date] => 2019-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8272 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16429042 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/429042
MEMBRANE AND METHOD FOR CULTURE AND DIFFERENTIATION OF CELLS Jun 1, 2019 Abandoned
Array ( [id] => 16793196 [patent_doc_number] => 20210123013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-29 [patent_title] => SYSTEM FOR CELL CULTURE IN A BIOREACTOR [patent_app_type] => utility [patent_app_number] => 17/057143 [patent_app_country] => US [patent_app_date] => 2019-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6706 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17057143 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/057143
SYSTEM FOR CELL CULTURE IN A BIOREACTOR May 19, 2019 Pending
Array ( [id] => 16525533 [patent_doc_number] => 20200399613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-24 [patent_title] => Cell Mass Fusion Method [patent_app_type] => utility [patent_app_number] => 16/969523 [patent_app_country] => US [patent_app_date] => 2019-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10980 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16969523 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/969523
Cell Mass Fusion Method Mar 26, 2019 Pending
Array ( [id] => 16627456 [patent_doc_number] => 20210046109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-18 [patent_title] => Suppressive Exosomes in Cancer and for Immunosuppression [patent_app_type] => utility [patent_app_number] => 16/980391 [patent_app_country] => US [patent_app_date] => 2019-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18957 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16980391 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/980391
Suppressive Exosomes in Cancer and for Immunosuppression Mar 13, 2019 Abandoned
Menu